{"AllianceGenome": "9869", "HGNC": "9869", "MIM": "605092", "_id": "5920", "_version": 1, "accession": {"genomic": ["AP001591.5", "CH471076.1", "CP068267.2", "KF455398.1", "NC_000011.10", "NC_060935.1"], "protein": ["AAC84000.1", "AAF02294.1", "AAH09678.1", "BAB08109.1", "BAG35046.1", "BAG56873.1", "BAH22446.1", "BBG06131.1", "EAW74156.1", "NP_004576.2", "Q9UL19.1"], "rna": ["AB030815.1", "AB453252.1", "AF060228.1", "AF092922.1", "AK293357.1", "AK312110.1", "BC009678.1", "DA973023.1", "LC420314.1", "NM_004585.5", "R55646.1"], "translation": [{"protein": "BAB08109.1", "rna": "AB030815.1"}, {"protein": "BAG56873.1", "rna": "AK293357.1"}, {"protein": "BAG35046.1", "rna": "AK312110.1"}, {"protein": "BAH22446.1", "rna": "AB453252.1"}, {"protein": "NP_004576.2", "rna": "NM_004585.5"}, {"protein": "AAC84000.1", "rna": "AF060228.1"}, {"protein": "AAH09678.1", "rna": "BC009678.1"}, {"protein": "AAF02294.1", "rna": "AF092922.1"}, {"protein": "BBG06131.1", "rna": "LC420314.1"}]}, "alias": ["HRASLS4", "HRSL4", "PLA1/2-3", "PLAAT-4", "RARRES3", "RIG1", "TIG3"], "ec": ["3.1.1.32", "3.1.1.4"], "ensembl": {"gene": "ENSG00000133321", "protein": ["ENSP00000255688", "ENSP00000346431", "ENSP00000402943"], "transcript": ["ENST00000255688", "ENST00000354445", "ENST00000439013", "ENST00000537871", "ENST00000544107"], "translation": [{"protein": "ENSP00000255688", "rna": "ENST00000255688"}, {"protein": "ENSP00000402943", "rna": "ENST00000439013"}, {"protein": "ENSP00000346431", "rna": "ENST00000354445"}], "type_of_gene": "protein_coding"}, "entrezgene": "5920", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.1749423, "exp_mis": 64.3533286, "exp_syn": 27.064914, "lof_z": 0.0761783891529115, "mis_z": -0.100400874099616, "mu_lof": 3.08781350007e-07, "mu_mis": 5.53184378734e-06, "mu_syn": 2.2407826369e-06, "n_lof": 5.0, "n_mis": 66.0, "n_syn": 26.0, "p_li": 0.000504117067056656, "p_null": 0.55323937939633, "p_rec": 0.446256503536614, "syn_z": 0.126899252560636}, "bp": 495, "cds_end": 63313728, "cds_start": 63304340, "n_exons": 4, "nonpsych": {"exp_lof": 4.6012798, "exp_mis": 58.1634316, "exp_syn": 24.41382, "lof_z": -0.182549605898092, "mis_z": 0.0769443865403774, "mu_lof": 3.08781350007e-07, "mu_mis": 5.53184378734e-06, "mu_syn": 2.2407826369e-06, "n_lof": 5.0, "n_mis": 57.0, "n_syn": 23.0, "p_li": 0.000387508017300903, "p_null": 0.628434585463064, "p_rec": 0.371177906519635, "syn_z": 0.18015226924253}, "nontcga": {"exp_lof": 4.75290129, "exp_mis": 59.1970208, "exp_syn": 24.89167968, "lof_z": -0.111807852943328, "mis_z": -0.2462542971111, "mu_lof": 3.08781350007e-07, "mu_mis": 5.53184378734e-06, "mu_syn": 2.2407826369e-06, "n_lof": 5.0, "n_mis": 63.0, "n_syn": 25.0, "p_li": 0.000407682531254299, "p_null": 0.593873371999963, "p_rec": 0.405718945468783, "syn_z": -0.0137468712991806}, "transcript": "ENST00000255688.3"}, "exons": [{"cdsend": 63546256, "cdsstart": 63536868, "chr": "11", "position": [[63536807, 63536877], [63539515, 63539624], [63544620, 63544889], [63546148, 63546458]], "strand": 1, "transcript": "NM_004585", "txend": 63546458, "txstart": 63536807}], "exons_hg19": [{"cdsend": 63313728, "cdsstart": 63304340, "chr": "11", "position": [[63304279, 63304349], [63306987, 63307096], [63312092, 63312361], [63313620, 63313930]], "strand": 1, "transcript": "NM_004585", "txend": 63313930, "txstart": 63304279}], "generif": [{"pubmed": 12879006, "text": "induction of TIG3 is associated with the suppression of anchorage-independent growth in certain aerodigestive tract cancer cells"}, {"pubmed": 12928434, "text": "TIG3 facilitates the terminal stages in keratinocyte differentiation via activation of type I transglutaminase"}, {"pubmed": 15742394, "text": "altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract."}, {"pubmed": 15850806, "text": "identification and characterization of the functional RA response element that is responsible for the RA-mediated induction of RIG1 gene"}, {"pubmed": 15856468, "text": "TIG3 is negatively regulated by an activated MEK-ERK signaling pathway in ovarian carcinoma."}, {"pubmed": 17196792, "text": "The proapoptotic and anti-RAS activities of RIG1 are primarily associated with the Golgi localization of the protein."}, {"pubmed": 17762858, "text": "the TIG3 N-terminal region is required for TIG3-dependent keratinocyte differentiation, and its removal converts TIG3 into a proapoptotic protein"}, {"pubmed": 19245694, "text": "The NC domain, especially the NC motif, plays the major role in RIG1-mediated pro-apoptotic activity. The RIG1(111-123) dodecapeptide exhibited strong pro-apoptotic activity and has potential as an anticancer drug."}, {"pubmed": 19615464, "text": "The tumor suppressors TIG3, HRASLS2 and H-rev107 are involved in the phospholipid metabolism with different physiological roles."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20588308, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21858038, "text": "Data suggest that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis."}, {"pubmed": 22009441, "text": "We conclude that TG1-catalysed cross-linking, regulated by TIG3, might play an important role in the formation of neuronal tau inclusions in certain tauopathies"}, {"pubmed": 22616991, "text": "RIG1 gene is a downstream target of p53 in cancer cell lines"}, {"pubmed": 22960220, "text": "Low RIG1 expression is associated with testis cancer."}, {"pubmed": 24401997, "text": "We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria and a segment of the N-terminal hydrophilic region targets the centrosome."}, {"pubmed": 24599174, "text": "These findings argue that TIG3 is involved in the control of keratinocyte differentiation and that loss of TIG3 in transformed cells contributes to the malignant phenotype."}, {"pubmed": 24867881, "text": "RARRES3 downregulation engages metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma."}, {"pubmed": 25361079, "text": "findings provide a new insight into the molecular link between p53, protein acylation and Wnt/beta-catenin signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins."}, {"pubmed": 25871522, "text": "the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death."}, {"pubmed": 26464031, "text": "Letter: Interleukin-22 inhibits tazarotene-induced gene 3 expression in keratinocytes via MAPK-ERK1/2 and JAK2/STAT3 signaling."}, {"pubmed": 26951515, "text": "Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma"}, {"pubmed": 28532996, "text": "Identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a"}, {"pubmed": 28639915, "text": "this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma"}, {"pubmed": 29496306, "text": "we observed frameshift mutations of RARRES3 in 11 cases of colorectal cancer"}, {"pubmed": 34871166, "text": "Overexpression screen of interferon-stimulated genes identifies RARRES3 as a restrictor of Toxoplasma gondii infection."}], "genomic_pos": {"chr": "11", "end": 63546462, "ensemblgene": "ENSG00000133321", "start": 63536808, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 63313934, "start": 63304281, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0006644", "pubmed": 20100577, "qualifier": "involved_in", "term": "phospholipid metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008285", "pubmed": 9843971, "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016042", "qualifier": "involved_in", "term": "lipid catabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0036152", "qualifier": "involved_in", "term": "phosphatidylethanolamine acyl-chain remodeling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045618", "pubmed": 17762858, "qualifier": "involved_in", "term": "positive regulation of keratinocyte differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0070292", "qualifier": "involved_in", "term": "N-acylphosphatidylethanolamine metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070292", "pubmed": 22825852, "qualifier": "involved_in", "term": "N-acylphosphatidylethanolamine metabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0150074", "pubmed": 17762858, "qualifier": "involved_in", "term": "positive regulation of protein-glutamine gamma-glutamyltransferase activity"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 17762858, "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004623", "qualifier": "enables", "term": "phospholipase A2 activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004623", "pubmed": [20100577, 22825852], "qualifier": "enables", "term": "phospholipase A2 activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [17762858, 22908223, 25416956, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008970", "qualifier": "enables", "term": "phospholipase A1 activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008970", "pubmed": 22825852, "qualifier": "enables", "term": "phospholipase A1 activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016410", "qualifier": "enables", "term": "N-acyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016410", "pubmed": 22825852, "qualifier": "enables", "term": "N-acyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016746", "qualifier": "enables", "term": "acyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0052739", "qualifier": "enables", "term": "phosphatidylserine 1-acylhydrolase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0052740", "qualifier": "enables", "term": "1-acyl-2-lysophosphatidylserine acylhydrolase activity"}]}, "homologene": {"genes": [[7955, 436896], [9544, 722189], [9598, 451277], [9606, 5920], [9615, 483772]], "id": 48290}, "interpro": {"desc": "LRAT domain", "id": "IPR007053", "short_desc": "LRAT_dom"}, "ipi": ["IPI00296991", "IPI00479609", "IPI00909431"], "map_location": "11q12.3", "name": "phospholipase A and acyltransferase 4", "other_names": ["HRAS-like suppressor 4", "RAR-responsive protein TIG3", "phospholipase A and acyltransferase 4", "phospholipase A/acyltransferase-4", "retinoic acid receptor responder (tazarotene induced) 3", "retinoic acid receptor responder 3", "retinoic acid receptor responder protein 3", "retinoic acid-inducible gene 1", "retinoid-inducible gene 1 protein", "tazarotene-induced gene 3 protein"], "pantherdb": {"HGNC": "9869", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"ZFIN": "ZDB-GENE-081022-92", "ortholog_type": "LDO", "panther_family": "PTHR13943", "taxid": 7955, "uniprot_kb": "B3DHR3"}], "uniprot_kb": "Q9UL19"}, "pathway": {"reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1482839", "name": "Acyl chain remodelling of PE"}, {"id": "R-HSA-1483206", "name": "Glycerophospholipid biosynthesis"}, {"id": "R-HSA-1483257", "name": "Phospholipid metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}]}, "pdb": ["2LKT", "2MY9", "7ZOT"], "pfam": "PF04970", "pharos": {"target_id": 110, "tdl": "Tchem"}, "prosite": "PS51934", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF255559", "relationship": "is"}, {"id": "GNF255560", "relationship": "is"}, {"id": "GNF255561", "relationship": "is"}, {"id": "GNF255562", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF164477", "relationship": "similar to"}, "GNF_hs-Origene": {"id": "GNF035758", "relationship": "similar to"}, "GNF_hs-druggable_siRNA": {"id": "GNF062972", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF012210", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF244768", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF111073", "relationship": "is"}, {"id": "GNF150714", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1"], "protein": "NP_004576.2", "rna": "NM_004585.5", "translation": {"protein": "NP_004576.2", "rna": "NM_004585.5"}}, "reporter": {"HG-U133_Plus_2": "204070_at", "HG-U95Av2": "33236_at", "HTA-2_0": "TC11000572.hg.1", "HuEx-1_0": "3333899", "HuGene-1_1": "7940775", "HuGene-2_1": "16726081"}, "summary": "Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008].", "symbol": "PLAAT4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419275"}, "unigene": "Hs.17466", "uniprot": {"Swiss-Prot": "Q9UL19", "TrEMBL": "A6NG31"}, "wikipedia": {"url_stub": "RARRES3"}}